Skip to content

Medical-device intelligence

OUY: Trichomonas Vaginalis Nucleic Acid Amplification Test System

FDA product code OUY: Trichomonas Vaginalis Nucleic Acid Amplification Test System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OUY
FDA device name
Trichomonas Vaginalis Nucleic Acid Amplification Test System
Device class
2
Regulation number
866.3860
Medical specialty
Immunology
Review panel
MI

FDA definition

In vitro nucleic acid amplification test for the qualitative detection of ribosomal rna from trichomonas vaginalis as an aid in the diagnosis of trichomoniasis from vaginal, cervical, urogenital and gynecological specimens from symptomatic patients
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

9 clearance records and 4 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Jan 9, 2013 to Nov 3, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202503
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

13 matching records
Device / recordCompany in FDA recordSourceSource date
2 in 1 Trichomonas / Gardnerella TestZ-0816-2026 · OUYGET TESTED INTERNATIONAL ABRecallDec 1, 2025FDA classification date
3 in 1 STI TestZ-0817-2026 · OUYGET TESTED INTERNATIONAL ABRecallDec 1, 2025FDA classification date
8 in 1 STI Test KitZ-0818-2026 · OUYGET TESTED INTERNATIONAL ABRecallDec 1, 2025FDA classification date
Aptima Trichomonas vaginalis AssayK231316 · OUYHologic, Inc.510(k)Nov 6, 2023FDA decision date
Kit BD Max CT/GC/TV; Catalog # 442970Z-2331-2019 · OUYBecton Dickinson & Co.RecallAug 22, 2019FDA record creation date
BD MAX CTGCTV2, BD MAX SystemK182692 · OUYBecton, Dickinson and Company510(k)Jan 8, 2019FDA decision date
BD MAX CT/GC/TV, BD MAX INSTRUMENTK151589 · OUYBecton, Dickinson and Company510(k)Sep 6, 2016FDA decision date
Xpert TV, Xpert Urine Specimen Collection Kit, GeneXpert Dx Systems (GX-I, GX-II, GX-IV, GX-XVI), GeneXpert Infinity-48, Genxpert Infinity-48s an…K161619 · OUYCepheid510(k)Aug 29, 2016FDA decision date
Solana Trichomonas AssayK161182 · OUYQuidel Corporation510(k)Aug 15, 2016FDA decision date
Xpert® TV Assay on the Cepheid GeneXpert Instrument Systems (GeneXpert Dx, GeneXpert Infinity-48, GeneXpert Infinity-48s, and GeneXpertInfinity-8…K151565 · OUYCepheid510(k)Oct 16, 2015FDA decision date
AmpliVue Trichomonas AssayK143329 · OUYQuidel Corporation510(k)Mar 17, 2015FDA decision date
BD PROBETEC TRICHOMONAS VAGINALIS (TV) QX AMPLIFIED DNA ASSAYK130268 · OUYBecton, Dickinson & CO510(k)Aug 23, 2013FDA decision date
APTIMA TRICHOMONAS VAGINALIS ASSAY - PANTHERK122062 · OUYGen-Probe, Inc.510(k)Jan 9, 2013FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗